{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:21:33Z","timestamp":1787574093964,"version":"build-2736575974"},"reference-count":67,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024PT5102"],"award-info":[{"award-number":["2024PT5102"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ60594"],"award-info":[{"award-number":["2025JJ60594"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472711"],"award-info":[{"award-number":["82472711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472789"],"award-info":[{"award-number":["82472789"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nasopharyngeal carcinoma (NPC) is considered a typical \u201chot\u201d tumor, yet its immune evasion mechanisms remain poorly defined, and immunotherapy efficacy is suboptimal. Attenuation of intrinsic tumor cell immunogenicity to evade T cell recognition and cytotoxicity represents a major route of tumor immune evasion, whose mechanistic basis is largely unelucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Multiplex immunofluorescence and immunohistochemistry were used to assess correlations between mitochondrial leucyl-transfer RNA synthetase 2 (LARS2) expression, CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell infiltration and immunotherapy response in NPC tissues. In vitro CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell co-cultures, immunodeficient nude mice and immunocompetent murine models were used to explore LARS2-dependent CD8\n                      <jats:sup>+<\/jats:sup>\n                      -mediated antitumor immunity. Blue native polyacrylamide gel electrophoresis (BN-PAGE), extracellular flux and other mitochondrial functional assays were performed to characterize the roles of LARS2 and leucine in electron transport chain (ETC) translation and oxidative phosphorylation (OXPHOS) activity. Chromatin immunoprecipitation-quantitative PCR, ELISA and flow cytometry analyzed epigenetic modifications, major histocompatibility complex class I (MHC-I) expression and antigen presentation. Leucine supplementation combined with anti-programmed cell death protein-1 (PD-1) therapy was tested in mouse models to evaluate in vivo therapeutic efficacy against NPC immune escape.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We demonstrated that LARS2, a gene mapped to the 3p21 chromosomal region, was significantly downregulated in NPC, and its expression is positively correlated with patient prognosis and response to immunotherapy. Through in vitro and in vivo experiments, we demonstrated that restoration of LARS2 expression accelerates the translation of mitochondrial ETC subunits, enhances OXPHOS, and upregulates MHC-I expression via an epigenetic mechanism. These effects work together to enhance tumor antigen presentation and augment CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell-mediated cytotoxicity. Furthermore, we demonstrated that a high-leucine diet increases LARS2 expression and improves the effectiveness of anti-PD-1 immunotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study uncovers a novel mechanism by which the tumor suppressor LARS2 inhibits immune evasion in NPC through upregulation of MHC-I, and highlights a high-leucine diet as a promising strategy to sensitize tumors to immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015098","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:25:42Z","timestamp":1787570742000},"page":"e015098","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma"],"prefix":"10.1136","volume":"14","author":[{"given":"Mei","family":"Yang","sequence":"first","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Institute of Clinical Medicine, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Mo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daixi","family":"Ren","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijia","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-2909","authenticated-orcid":false,"given":"Pan","family":"Chen","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiang","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"He","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqing","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyu","family":"Zu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Zeng","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-8173","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China"},{"name":"Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China"},{"name":"Furong Laboratory, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"2026082404250964000_14.8.e015098.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30956-0"},{"key":"2026082404250964000_14.8.e015098.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70320-5"},{"key":"2026082404250964000_14.8.e015098.3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2024.07.1687","article-title":"Subsequent Survival and Loss of Lifetime for Patients with Progression-Free 24 Months after Treatment in Nasopharyngeal Carcinoma: A Comprehensive Nationwide Population-Based Analysis","volume":"120","author":"Liu","year":"2024","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"2026082404250964000_14.8.e015098.4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S1470-2045(23)00232-2","article-title":"Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"24","author":"Liu","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026082404250964000_14.8.e015098.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2026082404250964000_14.8.e015098.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00302-8"},{"key":"2026082404250964000_14.8.e015098.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00594-4"},{"key":"2026082404250964000_14.8.e015098.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.08.033"},{"key":"2026082404250964000_14.8.e015098.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0204-y"},{"key":"2026082404250964000_14.8.e015098.10","first-page":"5365","article-title":"High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese","volume":"60","author":"Chan","year":"2000","journal-title":"Cancer Res"},{"key":"2026082404250964000_14.8.e015098.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00422-1"},{"key":"2026082404250964000_14.8.e015098.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3253"},{"key":"2026082404250964000_14.8.e015098.13","first-page":"3877","article-title":"High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma","volume":"61","author":"Lo","year":"2001","journal-title":"Cancer Res"},{"key":"2026082404250964000_14.8.e015098.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207632"},{"key":"2026082404250964000_14.8.e015098.15","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28252"},{"key":"2026082404250964000_14.8.e015098.16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3727\/000000006783981008","article-title":"Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma","volume":"16","author":"Yi","year":"2006","journal-title":"Oncol Res"},{"key":"2026082404250964000_14.8.e015098.17","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmn006"},{"key":"2026082404250964000_14.8.e015098.18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-110410-132531"},{"key":"2026082404250964000_14.8.e015098.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.03.019"},{"key":"2026082404250964000_14.8.e015098.20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cmet.2024.02.011","article-title":"Aging-induced tRNA(Glu)-derived fragment impairs glutamate biosynthesis by targeting mitochondrial translation-dependent cristae organization","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab"},{"key":"2026082404250964000_14.8.e015098.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00332-2"},{"key":"2026082404250964000_14.8.e015098.22","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.64064","article-title":"LARS2-Related Perrault Syndrome in Siblings With 46,XY Differences of Sex Development","volume":"197","author":"Adam","year":"2025","journal-title":"Am J Med Genet A"},{"key":"2026082404250964000_14.8.e015098.23","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0466-5","article-title":"Parkinson\u2019s disease is associated with DNA methylation levels in human blood and saliva","volume":"9","author":"Chuang","year":"2017","journal-title":"Genome Med"},{"key":"2026082404250964000_14.8.e015098.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00353","article-title":"Regulating Lars2 in mitochondria: A potential Alzheimer\u2019s therapy by inhibiting tau phosphorylation","volume":"21","author":"Qian","year":"2024","journal-title":"Neurotherapeutics"},{"key":"2026082404250964000_14.8.e015098.25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102630","article-title":"Decreased expression of mitochondrial aminoacyl-tRNA synthetases causes downregulation of OXPHOS subunits in type 2 diabetic muscle","volume":"61","author":"L\u00f3pez-Soldado","year":"2023","journal-title":"Redox Biol"},{"key":"2026082404250964000_14.8.e015098.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.04.017"},{"key":"2026082404250964000_14.8.e015098.27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4161\/cc.28921","article-title":"Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis","volume":"13","author":"Bao","year":"2014","journal-title":"Cell Cycle"},{"key":"2026082404250964000_14.8.e015098.28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407"},{"key":"2026082404250964000_14.8.e015098.29","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0134"},{"key":"2026082404250964000_14.8.e015098.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00339-z"},{"key":"2026082404250964000_14.8.e015098.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0390-6"},{"key":"2026082404250964000_14.8.e015098.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05605-0"},{"key":"2026082404250964000_14.8.e015098.33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"2026082404250964000_14.8.e015098.34","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80058-M"},{"key":"2026082404250964000_14.8.e015098.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2475-6"},{"key":"2026082404250964000_14.8.e015098.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00441-y"},{"key":"2026082404250964000_14.8.e015098.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tplants.2015.07.005"},{"key":"2026082404250964000_14.8.e015098.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00842-x"},{"key":"2026082404250964000_14.8.e015098.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.11.036"},{"key":"2026082404250964000_14.8.e015098.40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38407-7","article-title":"Clinical efficacy and biomarker analysis of dual PD-1\/CTLA-4 blockade in recurrent\/metastatic EBV-associated nasopharyngeal carcinoma","volume":"14","author":"Lim","year":"2023","journal-title":"Nat Commun"},{"key":"2026082404250964000_14.8.e015098.41","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgy108"},{"key":"2026082404250964000_14.8.e015098.42","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1575"},{"key":"2026082404250964000_14.8.e015098.43","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-017-0534-8","article-title":"The crosstalk between autophagic and endo-\/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses","volume":"10","author":"You","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2026082404250964000_14.8.e015098.44","doi-asserted-by":"publisher","DOI":"10.1038\/nature24627"},{"key":"2026082404250964000_14.8.e015098.45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.trecan.2021.07.006","article-title":"HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy","volume":"7","author":"Maggs","year":"2021","journal-title":"Trends Cancer"},{"key":"2026082404250964000_14.8.e015098.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00345-8"},{"key":"2026082404250964000_14.8.e015098.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.016"},{"key":"2026082404250964000_14.8.e015098.48","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1016\/j.cell.2024.09.048","article-title":"IRGQ-mediated autophagy in MHC class I quality control promotes tumor immune evasion","volume":"187","author":"Herhaus","year":"2024","journal-title":"Cell"},{"key":"2026082404250964000_14.8.e015098.49","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ccell.2023.08.014","article-title":"Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I","volume":"41","author":"Ferrari","year":"2023","journal-title":"Cancer Cell"},{"key":"2026082404250964000_14.8.e015098.50","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00765-5"},{"key":"2026082404250964000_14.8.e015098.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2024.08.029"},{"key":"2026082404250964000_14.8.e015098.52","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02191-3","article-title":"The IRF2\/CENP-N\/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis","volume":"40","author":"Qi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2026082404250964000_14.8.e015098.53","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1038\/s41467-020-18954-z","article-title":"Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells","volume":"11","author":"Valle","year":"2020","journal-title":"Nat Commun"},{"key":"2026082404250964000_14.8.e015098.54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41420-025-02670-y","article-title":"Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions","volume":"11","author":"Qiu","year":"2025","journal-title":"Cell Death Discov"},{"key":"2026082404250964000_14.8.e015098.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.006"},{"key":"2026082404250964000_14.8.e015098.56","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0013-8","article-title":"Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN\/AKT\/mTOR pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"2026082404250964000_14.8.e015098.57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cac2.12374","article-title":"Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities","volume":"42","author":"Ge","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"2026082404250964000_14.8.e015098.58","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00846-7"},{"key":"2026082404250964000_14.8.e015098.59","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq1053"},{"key":"2026082404250964000_14.8.e015098.60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025840118","article-title":"Activation of NF-\u03baB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026082404250964000_14.8.e015098.61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s43018-024-00895-x","article-title":"Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4\/6 causes tumor immunogenicity","volume":"6","author":"Liang","year":"2025","journal-title":"Nat Cancer"},{"key":"2026082404250964000_14.8.e015098.62","doi-asserted-by":"crossref","unstructured":"Lee MY , Jeon JW , Sievers C , et al . Antigen processing and presentation in cancer immunotherapy. J Immunother Cancer 2020;8.","DOI":"10.1136\/jitc-2020-001111"},{"key":"2026082404250964000_14.8.e015098.63","first-page":"737","article-title":"HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions","volume":"58","author":"Vitale","year":"1998","journal-title":"Cancer Res"},{"key":"2026082404250964000_14.8.e015098.64","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02276-z","article-title":"IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer","volume":"24","author":"Ranjan","year":"2025","journal-title":"Mol Cancer"},{"key":"2026082404250964000_14.8.e015098.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.09.011"},{"key":"2026082404250964000_14.8.e015098.66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41418-024-01285-7","article-title":"Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma","volume":"31","author":"Jin","year":"2024","journal-title":"Cell Death Differ"},{"key":"2026082404250964000_14.8.e015098.67","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-326928"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:25:46Z","timestamp":1787570746000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,24]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jitc-2026-015098"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015098","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}